Hybrid L24 New Enrollment Post Approval Study

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 14, 2022

Study Completion Date

April 14, 2022

Conditions
High Frequency Sensorineural Hearing Loss
Interventions
DEVICE

Nucleus Hybrid L24 Implant

Trial Locations (19)

15212

Pittsburgh Ear Associates, Pittsburgh

19104

Hospital of the University of Pennsylvania, Philadelphia

21204

Greater Baltimore Medical Center, Baltimore

33136

University of Miami, Miami

37232

Vanderbilt University Medical Center, Nashville

43082

Ohio Ear Institute, Westerville

45219

The University of Cincinnati, Cincinnati

48109

University of Michigan, Ann Arbor

48334

Michigan Ear Institute, Farmington Hills

52242

University of Iowa, Iowa City

60062

NorthShore University Health System, Northbrook

64111

Midwest Ear Institute, Kansas City

78258

Ear Institute of Texas, San Antonio

80045

University of Colorado Hospitals, Aurora

80110

Denver Ear Associates, Englewood

80113

Rocky Mountain Ear Center, Englewood

85004

Arizona Ear Center, Phoenix

95823

Kaiser Permanente South Sacramento, Sacramento

01803

Lahey Hospital and Medical Center, Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cochlear

INDUSTRY

NCT02379819 - Hybrid L24 New Enrollment Post Approval Study | Biotech Hunter | Biotech Hunter